Cosmo Bio Company,Limited announces an Equity Buyback for 160,000, representing 2.7% of its issued share capital shares, for ¥200 million.
February 12, 2021 at 01:00 am EST
Share
Cosmo Bio Company,Limited (JASDAQ:3386) announces a share repurchase program. Under the program, the company will repurchase up to 160,000 shares, representing 2.7% of its issued share capital, for a total purchase price of ¥200 million. The purpose of the program is to acquire its own shares in order to return profits to shareholders by improving capital efficiency and to enable flexible capital policy implementation in response to changes in the business environment. The program will continue through August 31, 2021. As of December 31, 2020, the company had 5,927,956 issued shares (excluding own shares) and 120,044 treasury shares.
COSMO BIO COMPANY,LIMITED is a Japan-based company mainly engaged in purchase and wholesale of research reagents, equipment, consignment services and clinical test drugs related to life science. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The Company provides clinical test drugs mainly used at hospitals and testing centers.
COSMO BIO COMPANY,LIMITED 
